Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher Robert Manz, M.D.

Concepts (98)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms232025223861.470 Why?
Prisoners320253171.440 Why?
Communication11202439101.310 Why?
Terminal Care3202417731.070 Why?
Medicare6202468810.830 Why?
Prospective Payment System120201360.660 Why?
SEER Program1202414760.650 Why?
Biomedical Technology120202100.600 Why?
Equipment and Supplies120202730.590 Why?
Drug Therapy120205040.560 Why?
Physician-Patient Relations4202432670.550 Why?
Patient-Centered Care1202414390.460 Why?
Reimbursement Mechanisms120196770.450 Why?
Life Expectancy1202012490.440 Why?
Qualitative Research1202431150.440 Why?
Benchmarking1201910580.410 Why?
Outpatients1202016070.410 Why?
Marketing120142240.410 Why?
Caregivers1202423020.400 Why?
Medical Oncology6202423470.400 Why?
Carcinoma, Hepatocellular1202423310.390 Why?
Prisons220251780.390 Why?
Physicians2202446150.390 Why?
Uterine Cervical Neoplasms1202320400.360 Why?
Advance Care Planning320226980.340 Why?
Immunotherapy, Adoptive1201915050.330 Why?
Liver Neoplasms1202443620.310 Why?
Death220236830.310 Why?
Drug Industry120147930.300 Why?
Humans3620257684510.240 Why?
Telemedicine1202231040.230 Why?
United States92025731210.230 Why?
Hospitalization12024108450.230 Why?
Breast Neoplasms22022211560.220 Why?
Electronic Health Records2202448770.210 Why?
Neoplasm Recurrence, Local1202194250.210 Why?
Antineoplastic Agents22024137080.200 Why?
Lung Neoplasms22024135890.200 Why?
Quality of Life22023134970.200 Why?
Health Services Accessibility1201955100.190 Why?
Phenylurea Compounds120245320.190 Why?
Colorectal Neoplasms1202169780.190 Why?
Female1820253969430.180 Why?
Documentation220249130.180 Why?
Aged1120251715200.170 Why?
Quinolines120247690.160 Why?
Social Justice120234860.150 Why?
Patient Care Planning120239040.150 Why?
Physician's Role120249270.140 Why?
Palliative Care2202336440.140 Why?
Economics, Hospital120192100.140 Why?
Middle Aged1120252234180.130 Why?
Gastrointestinal Neoplasms120249590.130 Why?
Male1220253647810.120 Why?
Tamoxifen120199680.120 Why?
Diffusion of Innovation120197300.120 Why?
Randomized Controlled Trials as Topic22022103580.110 Why?
Adaptation, Psychological1202426650.110 Why?
Family1202432080.110 Why?
Administration, Oral1202140410.110 Why?
Hospice Care120206790.100 Why?
Inappropriate Prescribing120142120.100 Why?
Carcinoma, Pancreatic Ductal1202317550.090 Why?
Health Promotion1202322150.090 Why?
Accidental Falls1201910810.090 Why?
Antineoplastic Agents, Hormonal1201915360.090 Why?
Lymphoma1201919070.090 Why?
Medication Adherence1202121900.080 Why?
Health Status Disparities1202118760.080 Why?
Retrospective Studies32024818340.080 Why?
Survival Analysis12021101250.080 Why?
Cohort Studies22022417970.080 Why?
Early Detection of Cancer1202332300.080 Why?
Aged, 80 and over22024596800.070 Why?
Prospective Studies22022549140.070 Why?
Algorithms32022141580.070 Why?
Pharmaceutical Preparations1201410890.070 Why?
Carcinoma, Renal Cell1202131970.070 Why?
Prognosis32022300280.060 Why?
Databases, Factual1202180810.060 Why?
Antibodies, Monoclonal1202392630.060 Why?
Healthcare Disparities1202134120.060 Why?
Adenocarcinoma1202364000.060 Why?
Pancreatic Neoplasms1202354420.060 Why?
Prevalence12021158800.060 Why?
Quality of Health Care1201943400.060 Why?
Incidence12021215520.050 Why?
Mucin 5AC12023960.050 Why?
Pandemics1202287530.050 Why?
Adult320252235420.030 Why?
Paclitaxel1202317370.030 Why?
Triage120219970.030 Why?
Critical Illness1202427540.020 Why?
Delivery of Health Care1202353670.020 Why?
Phenotype12022167120.010 Why?
Predictive Value of Tests12019154600.010 Why?
Antineoplastic Combined Chemotherapy Protocols12023118430.010 Why?
Risk Assessment12019243110.010 Why?
Manz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (98)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.